circ-PTEN functions as a tumor-inhibiting circRNA in NSCLC through post-transcriptionally regulating PTEN, hinting a promising diagnostic/prognostic biomarker as well as therapeutic target for NSCLC patients.
Circular RNA circ-PTEN elevates PTEN inhibiting the proliferation of non-small cell lung cancer cells.